NBW Capital LLC Invests $247,000 in Colgate-Palmolive (NYSE:CL)

NBW Capital LLC acquired a new position in Colgate-Palmolive (NYSE:CL) in the fourth quarter, HoldingsChannel reports. The firm acquired 3,097 shares of the company’s stock, valued at approximately $247,000.

A number of other hedge funds have also recently made changes to their positions in CL. Geode Capital Management LLC raised its holdings in Colgate-Palmolive by 0.6% during the 1st quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock valued at $1,309,583,000 after buying an additional 112,177 shares during the last quarter. Morgan Stanley raised its holdings in Colgate-Palmolive by 3.2% during the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after buying an additional 514,559 shares during the last quarter. Moneta Group Investment Advisors LLC raised its holdings in Colgate-Palmolive by 90,253.2% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after buying an additional 15,956,771 shares during the last quarter. Northern Trust Corp raised its holdings in Colgate-Palmolive by 0.5% during the 1st quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock valued at $793,971,000 after buying an additional 50,040 shares during the last quarter. Finally, Norges Bank bought a new stake in Colgate-Palmolive during the 4th quarter valued at $644,715,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Down 0.3 %

NYSE:CL traded down $0.27 on Thursday, reaching $86.48. 2,638,243 shares of the stock traded hands, compared to its average volume of 4,520,784. The company has a market capitalization of $71.09 billion, a price-to-earnings ratio of 31.21, a PEG ratio of 3.24 and a beta of 0.42. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $90.37. The company’s fifty day simple moving average is $86.97 and its 200 day simple moving average is $80.63.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.89 billion. During the same period in the previous year, the business posted $0.77 earnings per share. The business’s revenue for the quarter was up 6.9% on a year-over-year basis. Equities analysts predict that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a $0.50 dividend. The ex-dividend date is Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. Colgate-Palmolive’s payout ratio is currently 69.06%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a report on Monday, January 29th. The Goldman Sachs Group started coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price objective for the company. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. UBS Group increased their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, January 29th. Finally, Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Transactions at Colgate-Palmolive

In other news, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Noel R. Wallace sold 29,772 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the transaction, the chief executive officer now owns 301,343 shares of the company’s stock, valued at $25,330,892.58. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the transaction, the director now directly owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. Insiders sold 232,371 shares of company stock worth $19,505,099 over the last three months. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.